Long-acting Reconbinant human G-CSF(kexing)

N/A

Report date: 2025/09/29 16:32:39

Base Information

Drug NameLong-acting Reconbinant human G-CSF(kexing)
Drug Alias Name聚乙二醇化人粒 细胞刺激因子注射液GB-K02
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionColony stimulating factor 3 receptor agonists
TargetsColony stimulating factor 3 receptor
Therapy Area/IndicationsNeutropenia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesShandong Kexing Bio-Products Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShandong Kexing Bio-Products Co Ltd
Inactive CompaniesN/A
Active IndicationsNeutropenia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A